跳至主要内容
临床试验/NCT01299779
NCT01299779已完成不适用

The Incidence of Hyponatremia With Two Commonly Prescribed Purgatives for Colonoscopy-Polyethylene Glycol 3350 With a Sports Drink (PEG-SD) Compared to Polyethylene Glycol 3350 With Electrolyte Solution (PEG-ELS)

Thomas Jefferson University1 个研究点 分布在 1 个国家目标入组 460 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
460
试验地点
1
主要终点
Development of hyponatremia in the peri-colonoscopy period

研究概览

简要总结

Objective: To compare the incidence of peri-colonoscopy hyponatremia associated with PEG 3350 + sports drink (PEG-SD) versus PEG 3350-electrolyte solution + sodium sulfate + sodium ascorbate and ascorbic acid (PEG-ELS).

Hypothesis: As compared to PEG-SD, hyponatremia occurs significantly less often with PEG-ELS.

详细描述

Looking at the Incidence of Hyponatremia With Two Commonly Prescribed Purgatives for Colonoscopy-Polyethylene Glycol 3350 With a Sports Drink (PEG-SD) Compared to Polyethylene Glycol 3350 With Electrolyte Solution (PEG-ELS)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults age 18 years or older scheduled for elective outpatient colonoscopy: 8am - noon.

排除标准

  • Unable or unwilling to consent
  • Breast feeding
  • Significant psychiatric illness
  • > 50% colon resection
  • Bowel obstruction
  • History of hyponatremia (Serum sodium <135 mmol/L)
  • End stage renal disease on dialysis
  • History of chronic kidney disease (other than kidney stones)
  • Decompensated cirrhosis, including:
  • History of bleeding due to portal hypertension (varices, gastropathy, etc) within 3 months
  • Hepatic encephalopathy (not controlled with medications) within 3 months
  • Clinical presence of ascites
  • Active cardiac disease
  • Recent myocardial infarction (<4weeks)
  • Unstable angina
  • Congestive heart failure NYHA Functional Class Stage III or IV
  • Stage III: Marked limitation of activity. Less than ordinary activity (e.g. walking short distances, 20-100 m) causes fatigue, palpitations, dyspnea. Comfortable at rest.
  • Stage IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients.
  • Exclusion Criteria (post-enrollment), from baseline labs:
  • Serum creatinine > 1.5 mg/dL
  • Serum potassium < 3.3 or > 5.5 mmol/L
  • Serum sodium < 135 mmol/L or >150 mmol/L
  • Serum calcium < 8.0 or > 11.0 mg/dL

研究组 & 干预措施

PEG-ELS

Active Comparator

干预措施: PEG-ELS (Drug)

PEG-SD

Active Comparator

干预措施: PEG-SD (Drug)

结局指标

主要结局

Development of hyponatremia in the peri-colonoscopy period

时间窗: blood drawn 30 minutes post colonoscopy

次要结局

  • Development of serum electrolytes levels outside the normal range for(blood drawn 30 minutes post colonoscopy)
  • Change from baseline for serum electrolytes(blood drawn 30 minutes post colonoscopy)
  • Change in renal function from baseline(blood drawn pre colonoscopy and 30 minutes post colonoscopy)
  • Changes in the following from baseline a. Serum vasopressin b. Serum osmolality c. Urine electrolytes and osmolality(blood drawn pre colonoscopy and 30 minutes post colonoscopy)
  • Serum cortisol and TSH levels for only patients who develop hyponatremia(blood drawn 30 minutes post colonoscopy)
  • Hemodynamic/volume changes at baseline and immediately prior to colonoscopy(hemodynamic measurments taken pre and post colonoscopy)
  • Adverse Events - Incidence and severity using 10-point Likert scale(1 hour post colonoscopy assessment)
  • Prep Completion: <90% vs. > 90%(one time assessment pre colonoscopy)
  • Indication for colonoscopy: Screen/Surveillance vs. Symptom(one time assessment pre colonoscopy)
  • Assessment of independent risk factors for hyponatremia(one time assessment pre colonoscopy)
  • Efficacy(endoscopist will evaluate during colonoscopy)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验